Medzyme is a US-based biotech company founded by Chilean scientists and entrepreneurs, dedicated to the development of bacteriophage-based products for human health. Currently, Medzyme has joint research projects with Chilean hospitals to diagnose clinically important bacteria and discover new bacteriophages against pathogenic multidrug-resistant bacteria. Medzyme has the technical and commercial support of key partners, such as Phage Technologies, Praxis Biotech, and Fundación Ciencia & Vida.